Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Xiaoyong Qi"'
Autor:
Jie Wang, Yuehui Yin, Chengzhi Lu, Zhibing Lu, Jialu Hu, Yue Wang, Junbo Ge, Hong Jiang, Chen Yao, Xiaoyan Yan, Wei Ma, Xiaoyong Qi, Yi Dang, Shaoliang Chen, Jiancheng Zhu, Dongmei Wang, Chao Ding, Weimin Wang, Jian Liu, Yanbin Wang, Hui Li, Zhenhua Pan, Kaijun Cui, Chengzong Li, Xinjian Liang, Weijie Chen, Paul A. Sobotka, JingJing Zhang, Murray Esler, Ningling Sun, Minglong Chen, Yong Huo
Publikováno v:
EClinicalMedicine, Vol 72, Iss , Pp 102626- (2024)
Summary: Background: Previous trials of renal denervation (RDN) have been designed to investigate reduction of blood pressure (BP) as the primary efficacy endpoint using non-selective RDN without intraoperatively verified RDN success. It is an unmet
Externí odkaz:
https://doaj.org/article/33fb94ed9e164e3bb65a0428d1a4dd42
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Symptom-to-balloon time (SBT) represents the total ischemic time in ST-elevated myocardial infarction (STEMI) and is associated with poor long-term outcomes. The study aimed to explore the association between SBT and in-hospital m
Externí odkaz:
https://doaj.org/article/41ee498f731746c2a0410a83ad59bcdb
Autor:
Litong Qi, Jiyan Chen, Xiaodong Li, Xiaoyong Qi, Chunhua Ding, Xiaoping Chen, Xiang Gu, Wenliang Xiao, Shuiping Zhao, Yugang Dong, Mingqi Zheng, Kai Huang, Liangqiu Tang, Xiaomei Guo, Fang Wang, Guosheng Fu, Junxia Li, Yong Huo
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundTo evaluate the safety and efficacy of hybutimibe plus atorvastatin for lipid control in hypercholesterolemia patients with atherosclerotic cardiovascular disease risk equivalent.MethodsIn this double-blind phase III study, we 1:1 randomly
Externí odkaz:
https://doaj.org/article/b96ba4db993946558feb843b4bb828fb
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Currently, how to accurately determine the patient prognosis after a percutaneous coronary intervention (PCI) remains unclear and may vary among populations, hospitals, and datasets. The aim of this study was to establish a predic
Externí odkaz:
https://doaj.org/article/d2bf489b92f547e5b4accce9fc694948
Autor:
Xuefeng Chen, Qian Yang, Wenlou Bai, Wenjing Yao, Litian Liu, Yuanyuan Xing, Cunliang Meng, Peng Qi, Yi Dang, Xiaoyong Qi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Recent studies have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors play a beneficial role for normoglycemic patients with heart failure (HF). However, the underlying mechanism remains largely unexplored. In the present study, we aimed t
Externí odkaz:
https://doaj.org/article/905bd9754b8f4941addc657a8da40db6
Autor:
Wenjing Wang, Jiaqi Wang, Yudan Wang, Shengqi Jia, Man Gao, Shihang Zheng, Yi Dang, Yingxiao Li, Xiaoyong Qi
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/a668ca3090904fdeb38aac8b11e02caf
Publikováno v:
Journal of Interventional Cardiology, Vol 2022 (2022)
Background. Mortality after percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients with cardiogenic shock (CS) remains high. However, the real-world risk factors for mortality in these patients are poorly defi
Externí odkaz:
https://doaj.org/article/b454a42186e34454a837a852e7ed5633
Autor:
Jiaqi Wang, Feifei Zhang, Man Gao, Yudan Wang, Xuelian Song, Yingxiao Li, Yi Dang, Xiaoyong Qi
Publikováno v:
Cardiovascular Innovations and Applications, Vol 7, Iss 1, p 984 (2023)
Purpose: Coronary no-reflow phenomenon (NRP), a common adverse complication in patients with ST-segment elevation myocardial infarction (STEMI) treated by percutaneous coronary intervention (PCI), is associated with poor patient prognosis. In this st
Externí odkaz:
https://doaj.org/article/9d53e99978c3461e9ba304b48f026995
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
ST-segment elevation myocardial infarction is a type of coronary atherosclerotic heart disease, and its pathophysiological mechanism is formation of lipid plaques. We report a 19-year-old patient with ST-segment elevation myocardial infarction caused
Externí odkaz:
https://doaj.org/article/33cd98e0b5e14396bd8ac19184d528c3
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective Several recent studies have shown that the aldosterone synthase gene ( CYP11B2 ) −344C/T polymorphism is related to cardiovascular diseases. However, whether the −344C allele influences the incidence of cardiovascular diseases in Chines
Externí odkaz:
https://doaj.org/article/40e023f6f76145ad8d08fec3b1f1ad3a